LEADER 01391nam  2200337   450 
001 9910688148103321
005 20230702203426.0
035   $a(CKB)5580000000514506
035   $a(NjHacI)995580000000514506
035   $a(EXLCZ)995580000000514506
100   $a20230702d2022      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aDrug Development Life Cycle /$fedited by Juber Akhtar [and three others]
210  1$aLondon :$cIntechOpen,$d2022.
215   $a1 online resource (110 pages)
311   $a1-80356-049-5 
330   $aDrug authentication is generally governed by critical procedures. This book presents a comprehensive overview of drug design, highlighting the steps involved from the discovery phase to product approval. Chapters address such topics as drug development processes, pharmaceutical nanoformulations and cosmeceuticals for topical use, ocular drug delivery systems, and drug development involving computer-aided drug design, machine learning, and artificial intelligence.
606   $aDrug development
615  0$aDrug development.
676   $a615.19
702   $aAkhtar$b Juber
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688148103321
996   $aDrug Development Life Cycle$92994565
997   $aUNINA